Universidad San Sebastián  
 

Repositorio Institucional Universidad San Sebastián

Búsqueda avanzada

Descubre información por...

 

Título

Ver títulos
 

Autor

Ver autores
 

Tipo

Ver tipos
 

Materia

Ver materias

Buscar documentos por...




Mostrar el registro sencillo del ítem

dc.contributor.author Riquelme, Ian
dc.contributor.author Carrillanca, Daniela
dc.contributor.author Sánchez, Camila
dc.contributor.author Monterroza, Andrea
dc.contributor.author Hernández , Bairon
dc.contributor.author Riadi, Gonzalo
dc.contributor.author Cancino, Gonzalo I.
dc.contributor.author Murgas Alcaíno, Paola Patricia
dc.date.accessioned 2026-02-08T03:31:56Z
dc.date.available 2026-02-08T03:31:56Z
dc.date.issued 2025-12
dc.identifier.issn 0716-9760
dc.identifier.other Mendeley: dce20b58-7895-31fa-b880-cb2c740a73f9
dc.identifier.uri https://repositorio.uss.cl/handle/uss/20587
dc.description Publisher Copyright: © The Author(s) 2025.
dc.description.abstract Background: The Stimulator of Interferon Genes (STING) pathway is pivotal in innate immunity, facilitating the detection of cytosolic DNA and initiating type I interferon-dependent responses. In addition to its immunological roles, STING has been increasingly associated with metabolic regulation, since research indicates that its inhibition can diminish inflammation, lipid accumulation, and tissue damage in obesity and other metabolic disorders. The findings have prompted the suggestion of STING inhibition as a viable treatment approach for metabolic illness. Nonetheless, the physiological function of STING in lipid homeostasis under normal settings remains largely unexplored, as does the impact of its absence on metabolism throughout various life stages in the absence of disease. This information deficit is crucial, particularly in light of the increasing interest in the long-term pharmacological suppression of STING. Results: To examine the function of STING in lipid metabolism during physiological, non-pathological conditions throughout the lifespan, we assessed WT and STINGKO mice at various ages and discovered that STING deficiency results in a consistent increase in body weight, independent of alterations in locomotor activity or food consumption. STINGKO mice exhibited markedly increased circulation levels of triglycerides and total cholesterol. Histological and morphological analysis demonstrated augmented fat accumulation in adipose and hepatic tissues, despite the lack of nutritional or genetic metabolic stress. These findings indicate a crucial function for STING in the control of lipid homeostasis across the lifespan. Conclusions:In contrast to earlier research conducted under pathological conditions, our findings indicate that the total absence of STING expression in healthy contexts leads to heightened lipid accumulation in tissues and blood. These findings underscore an unforeseen function of STING as a modulator of lipid metabolism in the context of longevity. They caution against the prolonged use of STING inhibitors, as chronic STING suppression may lead to detrimental metabolic effects. This study offers new insights into the non-immune roles of STING, indicating its significance in preserving metabolic equilibrium throughout the lifetime. es
dc.language.iso eng
dc.relation.ispartof vol. 58 Issue: no. 1 Pages: 1
dc.source Biological Research
dc.title Loss of Stimulator of Interferon Genes (STING) Promotes Accumulation of Cholesterol and Tri-glycerides Throughout Life in Mice en
dc.title.alternative La pérdida de la proteína Estimuladora de Genes de Interferón (STING) promueve la acumulación de Colesterol y Triglicéridos a lo largo de la vida de ratones en
dc.type Artículo
dc.identifier.doi 10.1186/s40659-025-00624-3
dc.publisher.department Facultad de Medicina

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem